Borrelia B31 ViraChip ® IgG, IgM Test Kit

 

The Borrelia B31 ViraChip® IgG and IgM are protein microarrays for the qualitative detection of Borrelia burgdorferi antigens in human serum or CSF.

As a miniaturized immunoblot based on an enzyme immunoassay, the Borrelia B31 ViraChip® IgG and IgM use purified specific antigens of Borrelia burgdorferi sensu stricto (B31).

The Borrelia B31 ViraChip® IgG and IgM Test Kits are composed of 96 single breakable wells each placed in a standard microtiter plate. The test procedure can be performed with common ELISA processors. The ViraChip® Software controls the entire process including the analysis of the test results.

 

 

 

 

 

BorreliaB31ViraChip en

 

 

Product features

 

CDC-recommended antigens
Highly sensitive and specific result interpretation
 
Characteristic constellations of spot triplets
Differentiation between early and late stages of Lyme disease
 
All relevant controls are integrated on the Borrelia ViraChip® IgG and IgM
Safe interpretation according to guidelines and recommendations in the laboratory routine
 
High sensitivity by using native antigens in IgM
Serologic indication for an active infection
 
CSF analysis with 100 μl sample material
Efficient use of valuable sample material when neuroborreliosis is suspected

 

Fully automated procedure on ELISA processors

 

Automated evaluation with the ViraChip® Software

 

 

 

Order No. Product description
Units
     
V-BBCGOK Borrelia B31 ViraChip® IgG Test Kit 96 tests
V-BBCGDK Borrelia B31 ViraChip® IgG Deca Kit 960 tests
V-BBCMOK Borrelia B31 ViraChip® IgM Test Kit 96 tests
V-BBCMDK Borrelia B31 ViraChip® IgM Deca Kit 960 tests
V-BBCGPK Borrelia B31 ViraChip® IgG Positive Control 110 μl
V-BBCMPK Borrelia B31 ViraChip® IgM Positive Control 110 μl
V-BBCPNK Borrelia B31 ViraChip® IgG,A,M Negative Control  110 μl

 

Arbeitsanleitung     Downloads en